Skip to main content
Close
Home
Society of Hospital Medicine
Presented by Society of Hospital Medicine
Home
Twitter Facebook LinkedIn Instagram YouTube Hospital Medicine Exchange Email RSS Feed

M. Alexander Otto

M. Alexander Otto began his reporting career early in 1999 covering the pharmaceutical industry for a national pharmacists' magazine and freelancing for the Washington Post and other newspapers. He then joined BNA, now part of Bloomberg News, covering health law and the protection of people and animals in medical research. Alex next worked for the McClatchy Company. Based on his work, Alex won a year-long Knight Science Journalism Fellowship to MIT in 2008-2009. He joined the company shortly thereafter. Alex has a newspaper journalism degree from Syracuse (N.Y.) University and a master's degree in medical science -- a physician assistant degree -- from George Washington University. Alex is based in Seattle.

News

Age should not be a barrier to aggressive esophageal cancer treatment

Author:
M. Alexander Otto
Publish date: February 26, 2021

Comorbidities, fitness are what matters.

  • Read More

News

PET predicts response to endocrine therapy in ER+ breast cancer

Author:
M. Alexander Otto
Publish date: February 19, 2021

Researchers say they’ve found a way to predict response to endocrine therapy in patients with ER+ breast cancer...

  • Read More

News

Routine COVID-19 screening unnecessary for cancer outpatients

Author:
M. Alexander Otto
Publish date: February 19, 2021

Screening works well based on symptoms/exposures, according to a study.

  • Read More

News

RPLND deemed ‘attractive’ option for early metastatic seminoma

Author:
M. Alexander Otto
Publish date: February 16, 2021

The 2-year recurrence-free survival rate was 84% in a phase 2 trial.

  • Read More

News

CCR score can guide treatment decisions after radiation in prostate cancer

Author:
M. Alexander Otto
Publish date: February 13, 2021

The score can identify patients with a low risk of metastasis who could potentially skip androgen deprivation therapy.

  • Read More

News

Cemiplimab approved for locally advanced, metastatic basal cell carcinoma

Author:
M. Alexander Otto
Publish date: February 10, 2021

The approval is based on phase 2 trial results.

  • Read More

News

TBI beats chemoconditioning for ALL transplants in children

Author:
M. Alexander Otto
Publish date: February 4, 2021

Total body irradiation plus etoposide remains the conditioning regimen of choice.

  • Read More

News

New technique uses voice to evaluate thyroid nodules

Author:
M. Alexander Otto
Publish date: January 29, 2021

An investigational technique could improve tumor detection.

  • Read More

News

Even patients with cancer in remission at risk for severe COVID-19

Author:
M. Alexander Otto
Publish date: January 26, 2021

Cancer patients, regardless of their age, and even if they are in remission, should be prioritized for...

  • Read More

News

Tool predicts severe toxicity from chemo in older breast cancer patients

Author:
M. Alexander Otto
Publish date: January 21, 2021

The new scoring system outperformed existing tools.

  • Read More

News

Immunotherapy response linked to low TMB in recurrent glioblastoma

Author:
M. Alexander Otto
Publish date: January 20, 2021

Patients with recurrent glioblastoma appear more likely to respond to immunotherapy if they have low tumor...

  • Read More

Article

Color-imaging endoscopy improves detection of upper GI cancer

Author:
M. Alexander Otto
Publish date: January 15, 2021

Neoplastic lesions were detected in 60 patients (8%) with LCI versus 36 patients (4.8%) with WLI, which translated to a 1.67 times higher rate of...

  • Read More

News

A 4-point thrombocytopenia score was found able to rule out suspected HIT

Author:
M. Alexander Otto
Publish date: January 11, 2021

A low score – 3 points or less – has a negative predictive value of 99.8%, “so HIT is basically ruled out.”...

  • Read More

News

Caregiver burden of outpatient ASCT for multiple myeloma comparable with inpatient transplant

Author:
M. Alexander Otto
Publish date: December 18, 2020

But only if caregivers are equipped for outpatient care.

  • Read More

News

Cost is the main hurdle to broad use of caplacizumab for TTP

Author:
M. Alexander Otto
Publish date: December 7, 2020

“If we take finances out, I think almost every patient except those with a bleeding risk or bleeding problem should get it,” an investigator said...

  • Read More

Pages

  • « first
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • last »
An Official Publication of the Society of Hospital Medicine

Society of Hospital Medicine
Twitter Facebook LinkedIn Instagram YouTube Hospital Medicine Exchange Email RSS Feed

Copyright  © 2022 Frontline Medical Communications Inc., Newark, NJ, USA. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

Menu Close